Yüklüyor......
A Phase 2 Multi-center, Open-label, Switch-over Trial to Evaluate the Safety and Efficacy of Abcertin® in Patients with Type 1 Gaucher Disease
Gaucher disease is a lysosomal storage disease for which enzyme replacement therapy has proven to be effective. A switch-over clinical trial was performed to evaluate the efficacy and safety of Abcertin® (ISU Abxis, Seoul, Korea) in subjects with type 1 Gaucher disease who were previously treated wi...
Kaydedildi:
| Yayımlandı: | J Korean Med Sci |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
The Korean Academy of Medical Sciences
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4366957/ https://ncbi.nlm.nih.gov/pubmed/25829804 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2015.30.4.378 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|